文献速递主动脉疾病

EVAR术后瘤囊回缩与否:瘤囊行为结局的系统评价与荟萃分析

To regress or not to regress? Outcomes of aneurysm sac behavior after endovascular aortic aneurysm repair: A systematic review and meta-analysis.
PubMed 文献 · J Vasc Surg · 2026-03-14

该系统评价与荟萃分析纳入27项研究共36822例EVAR患者,比较瘤囊回缩与未回缩对围术期及长期结局的影响。结果显示瘤囊回缩与总体生存改善(HR 0.70;95%CI 0.61-0.80;P<.00001)、随访期内漏内漏风险降低(RR 0.55;95%CI 0.41-0.72;P<.0001)及无再干预生存改善(HR 0.37;95%CI 0.27-0.53;P<.00,001)相关,但在F/BEVAR亚组中部分结局未达统计学显著。

要点

  • EVAR术后瘤囊回缩与总体生存改善独立相关(HR 0.70)。
  • 瘤囊回缩者随访期漏内漏风险降低(RR 0.55)。
  • 瘤囊行为可作为EVAR术后监测与长期风险分层指标。

核心结论

  • EVAR术后瘤囊回缩相比未回缩与更优结局相关。
  • 瘤囊行为是EVAR术后监测和长期风险分层的重要指标。

研究设计与样本

  • 系统评价与荟萃分析,检索Medline、Embase和Cochrane数据库。
  • 纳入27项研究,共36822例EVAR患者。
  • 主要结局为总体生存,次要结局包括无再干预生存、随访期漏内漏、动脉瘤破裂和随访期再干预。
  • 二分类结局采用风险比(RR),长期结局采用风险比(HR),均计算95%置信区间(CI)。
  • 对纳入F/BEVAR患者的研究及比较瘤囊回缩与瘤囊稳定的研究进行亚组分析,并对短期结局进行试验序贯分析。

主要发现

  • 总体分析中,瘤囊回缩与总体生存改善相关(HR,0.70;95% CI,0.61-0.80;P < .00001)。
  • F/BEVAR亚组中,瘤囊回缩与死亡风险数值降低相关,但未达统计学显著(HR,0.87;95% CI,0.49-1.53;P = .62)。
  • 随访期漏内漏风险在总体分析(RR,0.55;95% CI,0.41-0.72;P < .0001)和F/BEVAR亚组(RR,0.55;95% CI,0.41-0.75;P = .0001)中均降低。
  • 瘤囊回缩者无再干预生存更优(HR,0.37;95% CI,0.27-0.53;P < .00,001),随访期再干预和动脉瘤破裂发生率更低,但F/BEVAR亚组中后两者未达统计学显著。
  • 在比较瘤囊回缩与瘤囊稳定的亚组分析中,所有结局的统计学显著性均持续存在。

临床怎么用

  • EVAR术后应将瘤囊回缩情况作为常规监测和长期风险分层的依据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the impact of aneurysmal sac regression vs failure to regress on perioperative and long-term outcomes after endovascular aortic aneurysm repair (EVAR). METHODS: Article screening was conducted using Medline, Embase, and the Cochrane databases. The primary outcome was overall survival; secondary outcomes included reintervention-free survival, endoleak during follow-up, aneurysmal rupture, and reintervention during follow-up. End points were compared using risk ratios (RRs) for binary outcomes and hazard ratios (HRs) for long-term outcomes. For all outcomes, 95% confidence intervals (CIs) were calculated. Subgroup analysis was done for studies including fenestrated/branched EVAR (F/BEVAR) patients and for studies comparing sac regression to sac stability. A trial sequential analysis was done for the short-term outcomes. Heterogeneity was assessed through the I2 statistic. GRADE assessment of the findings was performed. RESULTS: Twenty-seven studies comprising 36,822 patients were included. Sac regression was associated with improved overall survival in the overall analysis (HR, 0.70; 95% CI, 0.61-0.80; P < .00001). In the F/BEVAR subgroup, sac regression was associated with a numerically lower hazard of death; however, this association did not reach statistical significance (HR, 0.87; 95% CI, 0.49-1.53; P = .62). This association persisted for endoleak during follow-up, with lower risk observed in the overall analysis (RR, 0.55; 95% CI, 0.41-0.72; P < .0001) and in the F/BEVAR subgroup (RR, 0.55; 95% CI, 0.41-0.75; P = .0001). Patients with sac regression also demonstrated better reintervention-free survival (HR, 0.37; 95% CI, 0.27-0.53; P < .00,001) and a lower incidence of reintervention during follow-up and aneurysm rupture; however, these latter outcomes were not statistically significant within the F/BEVAR subgroup. Statistical significance persisted across all outcomes in the subgroup analysis comparing sac regression with stable sac. CONCLUSIONS: Sac regression after EVAR confers superior outcomes compared with failure to regress. Our findings underscore the importance of sac behavior as a key indicator in post-EVAR surveillance and long-term risk stratification.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Çetinel E, Khattak AI, Labib M, et al. To regress or not to regress? Outcomes of aneurysm sac behavior after endovascular aortic aneurysm repair: A systematic review and meta-analysis. J Vasc Surg. 2026. PMID: 41833592. doi:10.1016/j.jvs.2026.02.042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。